Показано 0 из 0
Дата |
---|
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
3.20
|
3.40
|
3.28
|
3.28
|
3.28
|
3.28
|
|
|
|
|
3.26
|
3.48
|
3.18
|
3.18
|
3.18
|
3.18
|
|
|
|
|
3.18
|
3.40
|
3.14
|
3.12
|
3.14
|
3.12
|
|
|
|
|
3.14
|
3.36
|
2.72
|
2.72
|
2.76
|
2.76
|
|
|
|
|
2.74
|
2.94
|
2.48
|
2.48
|
2.48
|
2.48
|
|
|
|
|
|
|
2.48
|
2.48
|
2.48
|
2.48
|
|
|
|
|
2.48
|
2.70
|
2.46
|
2.46
|
2.46
|
2.46
|
|
|
|
|
2.48
|
2.68
|
2.54
|
2.54
|
2.60
|
2.60
|
|
|
|
|
2.56
|
2.76
|
2.46
|
2.46
|
2.54
|
2.54
|
|
|
|
|
2.50
|
2.68
|
2.46
|
2.46
|
2.56
|
2.56
|
|
|
|
|
Guard Therapeutics International AB is engaged in developing and commercializing the lead drug candidate ROSgard, and thereby contribute to the better and less harmful treatment of acute kidney injuries.